Search Results - "LAW, Debbie"

Refine Results
  1. 1

    PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis by Woo, Jacky, Vierboom, Michel P M, Kwon, Hakju, Chao, Debra, Ye, Shiming, Li, Jianmin, Lin, Karen, Tang, Irene, Belmar, Nicole A, Hartman, Taymar, Breedveld, Elia, Vexler, Vladimir, 't Hart, Bert A, Law, Debbie A, Starling, Gary C

    Published in Arthritis research & therapy (01-01-2013)
    “…Targeting the CD20 antigen has been a successful therapeutic intervention in the treatment of rheumatoid arthritis (RA). However, in some patients with an…”
    Get full text
    Journal Article
  2. 2

    Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function by Phillips, David R, Law, Debbie A, DeGuzman, Francis R, Heiser, Patrick, Ministri-Madrid, Kathleen, Killeen, Nigel

    Published in Nature (London) (21-10-1999)
    “…Integrins not only bind adhesive ligands, they also act as signalling receptors. Both functions allow the integrin αIIbβ3 to mediate platelet aggregation…”
    Get full text
    Journal Article
  3. 3

    Functional Characterization of N297A, A Murine Surrogate for low-Fc Binding Anti-Human CD3 Antibodies by Chao, Debra T., Ma, Xiaohong, Li, Olga, Park, Hyunjoo, Law, Debbie

    Published in Immunological investigations (2009)
    “…Several low- or non-FcR binding anti-human CD3 monoclonal antibodies have been under investigation for the treatment of autoimmune diseases. To model the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model by Belmar, Nicole A, Lombardo, John R, Chao, Debra T, Li, Olga, Ma, Xiaohong, Pong-Afar, Melody, Law, Debbie A, Starling, Gary C

    Published in Journal of neuroimmunology (25-07-2009)
    “…Abstract Humanization and modification of the Fc region of anti-human CD3 mAbs have greatly expanded their potential use in chronic T cell mediated diseases…”
    Get full text
    Journal Article
  6. 6

    Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor by Gold, Michael R, Law, Debbie A, DeFranco, Anthony L

    Published in Nature (London) (28-06-1990)
    “…Signalling by membrane immunoglobulin, the B-lymphocyte antigen receptor, regulates B-cell maturation and activation. Crosslinking of membrane immunoglobulin…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Nanobodies – from llamas to therapeutic proteins by Kolkman, Joost A., Law, Debbie A.

    “…Antibodies have been a focus of drug development since the approval of Orthoclone ® OKT3 in 1986. However these large biologics are not without limitations…”
    Get full text
    Journal Article
  10. 10

    Tyrosine Phosphorylation of the β3 Cytoplasmic Domain Mediates Integrin-Cytoskeletal Interactions by Jenkins, Alison L., Nannizzi-Alaimo, Lisa, Silver, Debra, Sellers, James R., Ginsberg, Mark H., Law, Debbie A., Phillips, David R.

    Published in The Journal of biological chemistry (29-05-1998)
    “…Tyrosine phosphorylation of the β3 subunit of the major platelet integrin αIIbβ3 has been shown to occur during thrombin-induced platelet aggregation (1). We…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Tyrosine Phosphatases and the Antibody Response by DeFranco, Anthony L., Law, Debbie A.

    “…Research indicates that SH2-containing protein tyrosine phosphatases (PTP1C) play a major role in the regulation of signaling by receptors that use tyrosine…”
    Get full text
    Journal Article
  15. 15

    Outside-in Integrin Signal Transduction by Law, Debbie A., Nannizzi-Alaimo, Lisa, Phillips, David R.

    Published in The Journal of biological chemistry (03-05-1996)
    “…α β -(GPIIb-IIIa) is the most abundant integrin expressed on platelets and plays a critical role in platelet aggregation and normal hemostasis. In response…”
    Get full text
    Journal Article
  16. 16

    A Consideration of the Retention Ratio and the Impact on Selected Management and Investment Performance Metrics by Law, Debbie

    Published 01-01-2009
    “…They would possibly be less contentious if there was conclusive proof that managers were better allocators of capital generated through income retained than…”
    Get full text
    Dissertation
  17. 17

    Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies by Rice, Audie, Dillon, Myles, van Abbema, Anne, Jesaitis, Lynne, Wong, Melanie, Lawson, Stacey, Liu, Gao, Zhang, Yin, Powers, David, Rhodes, Susan, Caras, Ingrid, Law, Debbie, Afar, Daniel

    Published in Blood (16-11-2006)
    “…Introduction: We have recently shown that CS1 (CD2 subset 1, CRACC, SLAMF7), a cell surface glycoprotein of the CD2 family, is uniformly expressed on myeloma…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20